Lonza Group traded at 506.80 this Thursday December 1st, increasing 16.60 or 3.39 percent since the previous trading session. Looking back, over the last four weeks, Lonza Group gained 2.45 percent. Over the last 12 months, its price fell by 29.28 percent. Looking ahead, we forecast Lonza Group to be priced at 489.21 by the end of this quarter and at 449.53 in one year, according to Trading Economics global macro models projections and analysts expectations.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Peers Price Day Year
Covestro 37.36 -0.81 -2.12% -27.23%
Akzo Nobel 67.20 -1.02 -1.50% -28.16%
Alcon AG 65.48 1.42 2.22% -10.03%
Almirall SA 9.27 0.01 0.11% -13.65%
AstraZeneca 11,198.00 32.00 0.29% 36.05%
BASF 47.90 -0.62 -1.28% -18.93%
Bayer 55.23 -0.15 -0.27% 22.91%
Beiersdorf 105.40 1.45 1.39% 19.53%
DSM 123.70 1.40 1.14% -34.74%
Fresenius Medical Care 30.33 0.61 2.05% -43.44%
Fresenius 26.53 -0.03 -0.11% -21.58%
Geberit 461.80 15.00 3.36% -34.35%
Genmab 3,295.00 26.00 0.80% 34.33%
Givaudan 3,201.00 35.00 1.11% -29.31%
GN Store Nord 177.40 8.50 5.03% -52.14%
GlaxoSmithKline 1,414.20 7.40 0.53% -7.81%
Hikma Pharmaceutical 1,543.00 29.00 1.92% -29.96%
Johnson Matthey 2,071.00 -18.00 -0.86% 1.57%
Merck 176.95 3.15 1.81% -16.73%
Novartis 84.18 0.53 0.63% 14.07%
Philips 14.25 0.06 0.41% -54.16%
Roche Holding 309.45 1.65 0.54% -14.86%
Sanofi 87.16 0.68 0.79% 3.53%
Sika AG 244.50 7.50 3.16% -31.99%
Smith & Nephew PLC 1,074.00 -11.50 -1.06% -13.35%
Solvay 93.86 -0.02 -0.02% -6.84%
UCB 72.12 -4.66 -6.07% -25.42%
William Demant Holding 206.20 6.20 3.10% -32.26%

Indexes Price Day Year
CH20 11238 110.43 0.99% -7.71%

Lonza Group
Lonza Group AG (Lonza) is a Switzerland-based holding company and a supplier to the pharmaceutical, healthcare and life science industries. The Company's offerings include custom development and manufacturing of drugs and drug delivery systems, as well as development of anti-microbial solutions for commercial applications. The Company divides its activities into two segments: Pharma&Biotech and Specialty Ingredients. The Pharma&Biotech comprises the Company's Biologics, Small-Molecule, and Consumables and Research Tools businesses. The segment includes mammalian, microbial, chemical, bioconjugates, cell and gene therapy technology platforms. The Specialty Ingredients segment focuses on anti-microbial applications within Consumer Health division, which covers hygiene, nutrition and personal care products, as well as preservatives, capsules and food supplements, among others, and Consumer & Resources Protection division, which includes coatings and composites, and agro ingredients.